Old Web
English
Sign In
Acemap
>
Paper
>
Development of Lenvatinib Mesylate, an Angiogenesis Inhibitor Targeting VEGF and FGF Receptors
Development of Lenvatinib Mesylate, an Angiogenesis Inhibitor Targeting VEGF and FGF Receptors
2019
Akihiko Tsuruoka
Yasuhiro Funahashi
Junji Matsui
Tomohiro Matsushima
Keywords:
Fibroblast growth factor
Angiogenesis inhibitor
VEGF receptors
Receptor
Cancer research
Lenvatinib Mesylate
Medicine
Fibroblast growth factor receptor
antitumor activity
Thyroid cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
48
References
0
Citations
NaN
KQI
[]